RTTNews | Jul 30, 2020 07:11AM EDT

07:11 Thursday, July 30, 2020 (RTTNews.com) - Alexion Pharmaceuticals, Inc. (ALXN) said, for fiscal 2020, the company now expects non-GAAP earnings per share in a range of $10.65 to $10.95, revised from prior guidance range of $10.45 to $10.75. Total revenues are now projected in a range of $5.55 billion to $5.60 billion, revised from prior guidance range of $5.23 billion to $5.33 billion.

Second quarter non-GAAP earnings per share was $3.11, an 18 percent increase from the second quarter of 2019. On average, 20 analysts polled by Thomson Reuters expected the company to report profit per share of $2.59, for the quarter. Analysts' estimates typically exclude special items.

Second quarter net product sales were $1.45 billion, compared to $1.20 billion in the second quarter of 2019. Analysts expected revenue of $1.28 billion for the quarter.

Read the original article on RTTNews ( https://www.rttnews.com/3116208/alexion-raises-2020-total-revenues-non-gaap-eps-guidance-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved